• Resize Text
    • A
    • A
    • A
stars, based on reviews

Category: Home Sleep Testing

Apnea Risk Evaluation System (ARES™)
home sleep test

The Apnea Risk Evaluation System
(ARES™) integrates physiological data acquired in-home with clinical history
and anthropomorphic data to determine the presence and severity of Obstructive Sleep Apnea (OSA). ARES™ has been
cleared for use by the United States Food and Drug Administration (FDA), and is
ISO 13485 certified for Europe and Canada.

ARES™ Home Sleep test Device integrates:


A sleep-wearable, wireless
physiological recorder worn on the forehead that acquires and stores up to 3
nights of nocturnal data. ARES™ measures blood oxygen
saturation (SpO2) and pulse rate (reflectance pulse oximetry), airflow (by nasal
cannula connected to a pressure transducer), snoring levels (calibrated acoustic
microphone), head movement and head position (accelerometers). When worn in the
home, the ARES™ provides a better profile of the patient's
breathing during sleep in his/her normal environment. Audio and visual
indicators notify the user when the ARES™ requires adjustment,
thus increasing reliability of the device in the home. The small size of
ARES™ allows it to be comfortably worn in all sleep

ARES™ Screener:

A validated predictor of OSA risk (those in need of a sleep study
based on a predicted apnea/hypopnea index > 5 events/hour) and OSA severity
(i.e., minimal, mild, moderate or severe) using responses to questions about
body type, symptoms of daytime drowsiness, snoring, and other sleep-related
characteristics or health conditions associated with OSA. The results can be
used to rapidly screen large populations to determine a prior probability of
obstructive sleep apnea (OSA). The results are also used to supplement the
physiological data obtained in the ARES Sleep Apnea Study.

Would you like to place an order?

Product Order Request

Customer Reviews

   |   Write a Review
Extra Large Image